Marshall Sack
Impact in
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
- Osteoarthritis Treatment and Mechanisms
- Hepatology top 10%
- Hepatitis C virus research
Papers in
-
- Inflammatory mediators and NSAID effects 4
- Pharmacogenetics and Drug Metabolism 2
-
- Peroxisome Proliferator-Activated Receptors 2
- Co-authors
- Roy D. Altman (1 shared paper)Robert A. Blum (2 shared papers)Martin I. Freed (2 shared papers)Ann K. Miller (1 shared paper)Suzanne K. Swan (3 shared papers)Thomas Marbury (3 shared papers)Melton B. Affrime (1 shared paper)Sheila Jacobs (1 shared paper)
- Journals
- The Journal of Clinical Pharmacology (5 papers)Seminars in Arthritis and Rheumatism (1 paper)Clinical Therapeutics (1 paper)Annals of Pharmacotherapy (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesNew ZealandFrance
In The Last Decade
Marshall Sack
12 papers receiving 495 citations
Peers
Comparison fields: 5 of 76
- Rheumatology 146
- Hepatology 53
- Pharmacology 106
- Nephrology 39
- Pharmacology 40
Countries citing papers authored by Marshall Sack
This map shows the geographic impact of Marshall Sack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marshall Sack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marshall Sack more than expected).
Fields of papers citing papers by Marshall Sack
This network shows the impact of papers produced by Marshall Sack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marshall Sack. The network helps show where Marshall Sack may publish in the future.
Co-authors
The 25 scholars most cited alongside Marshall Sack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 91 | |
| 2 | Prognostic factors in polyarteritis. | 1975 | 80 |
| 3 | 2003 | 74 | |
| 4 | 1999 | 72 | |
| 5 | 2002 | 63 | |
| 6 | 2004 | 36 | |
| 7 | Phase I/II trial of recombinant methionyl human tumor necrosis factor binding protein PEGylated dimer in patients with active refractory rheumatoid arthritis. | 2000 | 34 |
| 8 | 2003 | 33 | |
| 9 | 2001 | 28 | |
| 10 | 1995 | 25 | |
| 11 | 1996 | 20 | |
| 12 | 1999 | 10 |
About Marshall Sack
Marshall Sack is a scholar working on Pharmacology, Molecular Biology, Rheumatology, Pharmacology and Infectious Diseases, having authored 12 papers that have together received 566 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (4 papers), Pharmacogenetics and Drug Metabolism (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Systemic Sclerosis and Related Diseases (1 paper), Osteoarthritis Treatment and Mechanisms (1 paper), Antifungal resistance and susceptibility (1 paper) and Vasculitis and related conditions (1 paper). The work is most often cited by research in Rheumatology (146 citations), Hepatology (53 citations), Pharmacology (106 citations), Nephrology (39 citations) and Pharmacology (40 citations). Marshall Sack has collaborated with scholars based in United States, New Zealand and France. Frequent co-authors include Roy D. Altman, Robert A. Blum, Martin I. Freed, Ann K. Miller, Suzanne K. Swan, Thomas Marbury, Melton B. Affrime, Sheila Jacobs, Larry W. Moreland and Amy L. Pittenger. Their work appears in journals such as The Journal of Clinical Pharmacology, Seminars in Arthritis and Rheumatism, Clinical Therapeutics, Annals of Pharmacotherapy and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.